CN103212116A - Method for constructing three-dimensional scaffold by polymorphous low-grade adenocarcinoma (PLGA)/calcium carbonate porous composite microsphere - Google Patents
Method for constructing three-dimensional scaffold by polymorphous low-grade adenocarcinoma (PLGA)/calcium carbonate porous composite microsphere Download PDFInfo
- Publication number
- CN103212116A CN103212116A CN2013101392867A CN201310139286A CN103212116A CN 103212116 A CN103212116 A CN 103212116A CN 2013101392867 A CN2013101392867 A CN 2013101392867A CN 201310139286 A CN201310139286 A CN 201310139286A CN 103212116 A CN103212116 A CN 103212116A
- Authority
- CN
- China
- Prior art keywords
- plga
- calcium carbonate
- porous composite
- composite microspheres
- microspheres
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004005 microsphere Substances 0.000 title claims abstract description 92
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 title claims abstract description 85
- 229910000019 calcium carbonate Inorganic materials 0.000 title claims abstract description 43
- 239000002131 composite material Substances 0.000 title claims abstract description 42
- 238000000034 method Methods 0.000 title claims abstract description 24
- 208000009956 adenocarcinoma Diseases 0.000 title 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 36
- 238000003756 stirring Methods 0.000 claims abstract description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000000839 emulsion Substances 0.000 claims abstract description 16
- 239000008367 deionised water Substances 0.000 claims abstract description 11
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 11
- 238000009210 therapy by ultrasound Methods 0.000 claims abstract description 5
- 238000001035 drying Methods 0.000 claims abstract description 4
- 238000011049 filling Methods 0.000 claims abstract description 3
- 239000003960 organic solvent Substances 0.000 claims abstract description 3
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims abstract 18
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 abstract description 4
- 239000007764 o/w emulsion Substances 0.000 abstract 1
- 239000012071 phase Substances 0.000 description 21
- 210000000988 bone and bone Anatomy 0.000 description 12
- 238000010586 diagram Methods 0.000 description 12
- 238000012876 topography Methods 0.000 description 11
- 239000002904 solvent Substances 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 6
- -1 polytetrafluoroethylene Polymers 0.000 description 5
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 5
- 239000004810 polytetrafluoroethylene Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000005541 medical transmission Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
Images
Landscapes
- Manufacturing Of Micro-Capsules (AREA)
Abstract
本发明公开了一种利用PLGA/碳酸钙多孔复合微球无损构建三维支架的方法,包括以下步骤:a.将PLGA和碳酸钙添加到二氯甲烷有机溶剂中,通过搅拌和超声处理后,得到PLGA/碳酸钙的均匀混合油相;b.在搅拌条件下将上述油相分散到PVA水溶液中得到水包油的单乳液;c.搅拌乳液一定时间,使油相液滴中的二氯甲烷挥发,得到固化的复合微球;d.收集所得复合微球,用去离子水洗涤;e.将洗涤后的微球填入到模具中,在常温低压下干燥一定时间得到微球支架;f.移除模具,继续干燥支架至完全。本发明在温和条件下将多孔微球粘结成支架,微球表面的多孔结构得以完整保留。
The invention discloses a method for nondestructively constructing a three-dimensional scaffold by using PLGA/calcium carbonate porous composite microspheres, comprising the following steps: a. Adding PLGA and calcium carbonate to the organic solvent of dichloromethane, after stirring and ultrasonic treatment, a uniform mixed oil phase of PLGA/calcium carbonate is obtained; b. Disperse the above oil phase into PVA aqueous solution under stirring conditions to obtain a single oil-in-water emulsion; c. Stir the emulsion for a certain period of time to volatilize the dichloromethane in the oil phase droplets to obtain solidified composite microspheres; d. Collect the resulting composite microspheres and wash with deionized water; e. Filling the washed microspheres into the mold, drying at room temperature and low pressure for a certain period of time to obtain the microsphere scaffold; f. Remove the mold and continue drying the brackets to completion. The invention bonds the porous microspheres into a scaffold under mild conditions, and the porous structure on the surface of the microspheres is completely preserved.
Description
技术领域technical field
本发明涉及三维支架的制备方法,特别涉及一种由PLGA/碳酸钙多孔复合微球构建三维支架的方法。The invention relates to a preparation method of a three-dimensional support, in particular to a method for constructing a three-dimensional support from PLGA/calcium carbonate porous composite microspheres.
背景技术Background technique
骨缺损是目前临床最常见的疾病之一,而骨本身的修复能力有限,对于较严重骨缺损的治疗,需要借助骨移植来辅助修复。自体骨移植是最理想的修复方式,但是其来源受限;异体骨和异种骨移植存在疾病传播以及免疫排斥等风险。在这种背景下,基于支架的骨修复越来越受到人们的关注。支架是一个能够为组织长入和血管再生提供空间的三维结构体,还能充当传递药物和细胞的载体。聚合物微球是一种优良的药物载体,能够负载和控制释放多种药物。由聚合物微球构建的支架理论上具备百分百连通的孔隙结构,且其孔隙率也能满足骨修复的需求;由载药微球构成的支架还能够释放针对性的治疗药物,能够进一步增强支架的骨修复能力。因此,微球支架在骨修复方面有着良好应用前景。Bone defect is one of the most common clinical diseases at present, and the repair ability of bone itself is limited. For the treatment of more serious bone defects, bone grafting is needed to assist repair. Autologous bone grafting is the ideal repair method, but its source is limited; allogeneic bone and xenograft bone grafts have risks of disease transmission and immune rejection. Against this background, scaffold-based bone repair has received increasing attention. A scaffold is a three-dimensional structure that provides space for tissue ingrowth and blood vessel regeneration, and can also serve as a carrier for drug and cell delivery. Polymer microspheres are an excellent drug carrier, capable of loading and controlling the release of various drugs. The scaffold constructed of polymer microspheres theoretically has a 100% connected pore structure, and its porosity can also meet the needs of bone repair; the scaffold composed of drug-loaded microspheres can also release targeted therapeutic drugs, which can further Enhance the bone repair ability of the scaffold. Therefore, the microsphere scaffold has a good application prospect in bone repair.
聚乳酸乙醇酸共聚物(polylactic glycolic acid,PLGA)是一种具有良好生物相容性和生物降解性的材料,是为数不多的得到FDA批准使用的聚合物生物材料之一。关于PLGA微球和微球支架的骨修复应用研究一直都受到人们的关注。Y Wang等(Y Wang,X Shi,L Ren,Y Yao,F Zhang,D-A Wang J Biomed Mater ResPart B201093B84-92)制备了PLGA/钛复合微球支架,成骨细胞在其上能够良好地生长和代谢。A Jaklenec等(A Jaklenec,A Hinckfuss,B Bilgen,D Ciombor,RAaron,E Mathiowitz Biomaterials2008291518-1525)制备了能够顺序释放两种生长因子的PLGA支架。Polylactic glycolic acid (PLGA) is a material with good biocompatibility and biodegradability, and it is one of the few polymer biomaterials approved by the FDA. The research on the bone repair application of PLGA microspheres and microsphere scaffolds has always attracted people's attention. Y Wang et al. (Y Wang, X Shi, L Ren, Y Yao, F Zhang, D-A Wang J Biomed Mater ResPart B201093B84-92) prepared PLGA/titanium composite microsphere scaffolds, on which osteoblasts can grow well and metabolism. A Jaklenec et al. (A Jaklenec, A Hinckfuss, B Bilgen, D Ciombor, RAaron, E Mathiowitz Biomaterials2008291518-1525) prepared a PLGA scaffold capable of sequentially releasing two growth factors.
目前制备PLGA微球支架主要有两种方法:温度处理和溶剂处理。温度处理就是将微球加热到一定温度,使微球的聚合物分子链从玻璃态进入高弹态,分子链具备流动性,相邻的微球就会产生分子链的缠联。当温度降低后,聚合物分子链重新进入玻璃态,使微球之间形成永久性粘结。溶剂处理是将微球接触挥发性的溶剂,使微球表面区域的聚合物产生一定的溶解,相邻微球的表面相互融合。当溶剂挥发以后,微球表面重新固化从而在微球之间形成永久性的粘结。魏坤等(CN201110243418.1)公开了一种利用温度处理构建PLGA/纳米碳酸钙微球支架的方法;T Jiang(T Jiang,W Abdel-Fatah,C Laurencin Biomaterials2006274894-4903)等利用温度处理制备了PLGA/壳聚糖复合微球支架。赵亮(CN201110215643.4)公开了一种利用挥发性无水乙醇制备的PLGA载药微球支架;J Brown等(J Brown,L Nair,C Laurencin J Biomed Mater Res Part B200886B396-406)利用丙酮/乙醇混合溶剂制备了PLGA微球支架。然而温度和溶剂处理都不可避免地会对微球表面的微观结构产生破坏,从而无法得到结构更为精细可控的微球支架。虽然人们尝试用别的方法构建微球支架,例如高长有等(CN201210121194.1)公开了一种利用冷冻去溶剂制备PLGA微球支架的方法,但是这种方法难以在支架表面构建多孔形貌。由此可见,如何制备出具有精细结构的微球支架仍有待进一步探索研究。Currently, there are two main methods for preparing PLGA microsphere scaffolds: temperature treatment and solvent treatment. The temperature treatment is to heat the microspheres to a certain temperature, so that the polymer molecular chains of the microspheres enter the high elastic state from the glass state, the molecular chains have fluidity, and the adjacent microspheres will generate molecular chain entanglement. When the temperature is lowered, the polymer chains re-enter the glassy state, forming a permanent bond between the microspheres. Solvent treatment is to expose the microspheres to a volatile solvent, so that the polymer in the surface area of the microspheres will dissolve to a certain extent, and the surfaces of adjacent microspheres will fuse with each other. When the solvent evaporates, the surface of the microspheres recurs to form a permanent bond between the microspheres. Wei Kun et al. (CN201110243418.1) disclosed a method of using temperature treatment to construct PLGA/nano-calcium carbonate microsphere scaffold; T Jiang (T Jiang, W Abdel-Fatah, C Laurencin Biomaterials2006274894-4903) etc. prepared PLGA/chitosan composite microsphere scaffold. Zhao Liang (CN201110215643.4) disclosed a PLGA drug-loaded microsphere scaffold prepared by volatile absolute ethanol; J Brown et al. (J Brown, L Nair, C Laurencin J Biomed Mater Res Part B200886B396-406) used Mixed solvents were used to prepare PLGA microsphere scaffolds. However, both temperature and solvent treatment will inevitably destroy the microstructure of the microsphere surface, making it impossible to obtain a microsphere scaffold with a finer and more controllable structure. Although people try to use other methods to construct microsphere scaffolds, for example, Gao Changyou et al. (CN201210121194.1) disclosed a method for preparing PLGA microsphere scaffolds by freezing and desolvating, but this method is difficult to construct porous morphology on the surface of the scaffold . It can be seen that how to prepare microsphere scaffolds with fine structures still needs to be further explored.
发明内容Contents of the invention
为了克服现有技术的上述缺点与不足,本发明的目的在于提供一种由PLGA/碳酸钙多孔复合微球构建三维支架的无损制备方法,避免对微球进行温度和溶剂处理,从而能够完整保留微球表面形貌。In order to overcome the above-mentioned shortcomings and deficiencies of the prior art, the object of the present invention is to provide a non-destructive preparation method for constructing a three-dimensional scaffold by PLGA/calcium carbonate porous composite microspheres, avoiding temperature and solvent treatment of the microspheres, thereby enabling complete retention Microsphere surface morphology.
本发明的目的通过以下技术方案实现:The object of the present invention is achieved through the following technical solutions:
一种由PLGA/碳酸钙多孔复合微球构建三维支架的方法,包括以下步骤:A method for constructing a three-dimensional support by PLGA/calcium carbonate porous composite microspheres, comprising the following steps:
a.将PLGA和碳酸钙添加到二氯甲烷有机溶剂中,通过搅拌处理和超声处理后,得到PLGA/碳酸钙的均匀混合油相;a. PLGA and calcium carbonate are added to the methylene chloride organic solvent, and after stirring and ultrasonic treatment, a uniform mixed oil phase of PLGA/calcium carbonate is obtained;
b.在搅拌条件下将步骤a得到的油相分散到PVA水相中得到水包油的单乳液;b. Dispersing the oil phase obtained in step a into the PVA water phase under stirring conditions to obtain an oil-in-water single emulsion;
c.以200~400rpm的速率搅拌单乳液12~24h,使油相液滴中的二氯甲烷挥发,得到固化的复合微球;c. Stir the single emulsion at a rate of 200-400rpm for 12-24 hours to volatilize the dichloromethane in the oil phase droplets to obtain solidified composite microspheres;
d.收集所得复合微球,用去离子水充分洗涤;d. The resulting composite microspheres were collected and fully washed with deionized water;
e.将洗涤后的微球填入到模具中,在温度为20~25℃、压力为0.8~1MPa下干燥2~4h,得到初态支架;e. Filling the washed microspheres into a mold, drying at a temperature of 20-25°C and a pressure of 0.8-1MPa for 2-4 hours to obtain an initial scaffold;
f.移除模具,继续干燥至完全,得到由PLGA/碳酸钙多孔复合微球构成的三维支架。f. Remove the mold and continue to dry until complete to obtain a three-dimensional scaffold composed of PLGA/calcium carbonate porous composite microspheres.
步骤a中PLGA与二氯甲烷的质量体积比为(1/10~1/5)g/ml;碳酸钙与PLGA的质量比为1/20~1/2。In step a, the mass volume ratio of PLGA to methylene chloride is (1/10-1/5) g/ml; the mass ratio of calcium carbonate to PLGA is 1/20-1/2.
步骤a中所述搅拌处理,具体为:搅拌速度250~400rpm,搅拌时间为5~15min。The stirring treatment in step a is specifically: the stirring speed is 250-400 rpm, and the stirring time is 5-15 min.
步骤a中所述超声处理,具体为:超声功率为250~350w,超声时间为5~15min。The ultrasonic treatment described in step a specifically includes: the ultrasonic power is 250-350w, and the ultrasonic time is 5-15 minutes.
所述PLGA的分子量Mw=50~100kDa,,其中LA/GA=75/25。The molecular weight Mw of the PLGA is 50-100kDa, wherein LA/GA=75/25.
步骤b中PVA水相中PVA的浓度为(1/500~1/100)g/ml。The concentration of PVA in the PVA aqueous phase in step b is (1/500-1/100) g/ml.
步骤b中,油相与PVA水相的体积比为1/100~1/50。In step b, the volume ratio of the oil phase to the PVA water phase is 1/100˜1/50.
步骤c中,搅拌速率为200~400rpm,搅拌时间为12~24h。In step c, the stirring rate is 200-400 rpm, and the stirring time is 12-24 hours.
步骤f中,继续干燥至完全的具体时间为36~72h。In step f, the specific time for continuing to dry to complete is 36-72 hours.
与现有技术相比,本发明具有以下优点和有益效果:Compared with the prior art, the present invention has the following advantages and beneficial effects:
本发明以洗涤后的湿态微球作为三维支架构建单元,由于微球在常温下仍然具有一定粘结性能,无需对微球进行传统的温度或溶剂处理,从而避免支架制备步骤对微球表面形貌产生破坏。本发明由于完整保留了微球的表面形貌,微球支架得以保持更为精细的结构。通过制备不同形貌的微球,还可以得到不同形貌的支架。In the present invention, the washed wet microspheres are used as three-dimensional scaffold construction units. Since the microspheres still have a certain bonding performance at room temperature, there is no need to perform traditional temperature or solvent treatment on the microspheres, thereby avoiding damage to the surface of the microspheres in the preparation step of the scaffold. The shape is destroyed. Because the present invention completely retains the surface morphology of the microspheres, the microsphere bracket can maintain a finer structure. By preparing microspheres with different shapes, scaffolds with different shapes can also be obtained.
附图说明Description of drawings
图1为实施例1制备的复合微球表面形貌图。Fig. 1 is the surface morphology diagram of the composite microsphere prepared in Example 1.
图2为实施例1制备的三维支架的表面形貌图。FIG. 2 is a surface topography diagram of the three-dimensional scaffold prepared in Example 1.
图3为实施例2制备的三维支架的表面形貌图。3 is a surface topography diagram of the three-dimensional scaffold prepared in Example 2.
图4为实施例3制备的三维支架的表面形貌图。FIG. 4 is a surface topography diagram of the three-dimensional scaffold prepared in Example 3.
图5为实施例4制备的三维支架的表面形貌图。FIG. 5 is a surface topography diagram of the three-dimensional scaffold prepared in Example 4.
图6为实施例5制备的三维支架的表面形貌图。Fig. 6 is a surface topography diagram of the three-dimensional scaffold prepared in Example 5.
具体实施方式Detailed ways
下面结合实施例,对本发明作进一步地详细说明,但本发明的实施方式不限于此。The present invention will be described in further detail below in conjunction with the examples, but the embodiments of the present invention are not limited thereto.
实施例1Example 1
称取0.5g PLGA(LA/GA=75/25,Mw=100kDa)和0.2g碳酸钙粉末加入到5ml二氯甲烷中,在400rpm转速搅拌5min,再在300w超声功率下以300rpm的转速搅拌10min,得到PLGA/碳酸钙的均匀混合油相。称取2g PVA加入到250ml去离子水中,搅拌15min后加热到90℃使PVA溶解,冷却后得到PVA水相。在转速为400rpm搅拌条件下将油相逐滴加入到PVA水溶液中,得到水包油的单乳液,其中油相与水相的体积比为1/50。持续搅拌单乳液24h,得到PLGA/碳酸钙多孔复合微球。收集固化的复合微球,用去离子水洗涤3遍。然后将微球填入到聚四氟乙烯模具中,在温度20℃、压力0.8MPa下干燥4h,得到初态支架。脱模,继续干燥72h,得到由PLGA/碳酸钙多孔复合微球构成的三维支架。Weigh 0.5g PLGA (LA/GA=75/25, Mw=100kDa) and 0.2g calcium carbonate powder into 5ml dichloromethane, stir at 400rpm for 5min, then stir at 300rpm for 10min under 300w ultrasonic power , to obtain a uniform mixed oil phase of PLGA/calcium carbonate. Weigh 2g of PVA and add it to 250ml of deionized water, stir for 15min, heat to 90°C to dissolve the PVA, and obtain the PVA water phase after cooling. The oil phase was added dropwise into the PVA aqueous solution under the stirring condition of 400 rpm to obtain an oil-in-water single emulsion, wherein the volume ratio of the oil phase to the water phase was 1/50. The single emulsion was continuously stirred for 24 hours to obtain PLGA/calcium carbonate porous composite microspheres. The solidified composite microspheres were collected and washed 3 times with deionized water. Then the microspheres were filled into a polytetrafluoroethylene mold, and dried at a temperature of 20° C. and a pressure of 0.8 MPa for 4 hours to obtain an initial scaffold. Remove the mold and continue to dry for 72 hours to obtain a three-dimensional scaffold composed of PLGA/calcium carbonate porous composite microspheres.
图1为本实施例制备的PLGA/碳酸钙多孔复合微球表面形貌图。Fig. 1 is the surface topography diagram of the PLGA/calcium carbonate porous composite microsphere prepared in this example.
图2为本实施例制备的由PLGA/碳酸钙多孔复合微球构成的三维支架的表面形貌图。由图可知,支架表面的多孔结构保留完好,未受支架制备工艺的影响。Fig. 2 is the surface topography diagram of the three-dimensional scaffold composed of PLGA/calcium carbonate porous composite microspheres prepared in this example. It can be seen from the figure that the porous structure on the surface of the scaffold remains intact and is not affected by the preparation process of the scaffold.
实施例2Example 2
称取0.5g PLGA(LA/GA=75/25,Mw=100kDa)和0.025g碳酸钙粉末加入到5ml二氯甲烷中,在250rpm转速搅拌15min,再在250w超声功率下以250rpm的转速搅拌15min,得到PLGA/碳酸钙的均匀混合油相。称取1g PVA加入到500ml去离子水中,搅拌15min后加热到90℃使PVA溶解,冷却后得到PVA水相。在转速为200rpm搅拌条件下将油相逐滴加入到PVA水溶液中,得到水包油的单乳液,其中油相与水相的体积比为1/100。持续搅拌单乳液24h,得到PLGA/碳酸钙多孔复合微球。收集固化的复合微球,用去离子水洗涤3遍。然后将微球填入到聚四氟乙烯模具中,在温度25℃、压力1MPa下干燥2h,得到初态支架。脱模,继续干燥36h,得到由PLGA/碳酸钙多孔复合微球构成的三维支架。Weigh 0.5g PLGA (LA/GA=75/25, Mw=100kDa) and 0.025g calcium carbonate powder into 5ml dichloromethane, stir at 250rpm for 15min, then stir at 250rpm for 15min under 250w ultrasonic power , to obtain a uniform mixed oil phase of PLGA/calcium carbonate. Weigh 1g of PVA and add it to 500ml of deionized water, stir for 15min, heat to 90°C to dissolve the PVA, and obtain the PVA water phase after cooling. The oil phase was added dropwise into the PVA aqueous solution under the stirring condition of 200 rpm to obtain an oil-in-water single emulsion, wherein the volume ratio of the oil phase to the water phase was 1/100. The single emulsion was continuously stirred for 24 hours to obtain PLGA/calcium carbonate porous composite microspheres. The solidified composite microspheres were collected and washed 3 times with deionized water. Then the microspheres were filled into a polytetrafluoroethylene mold, and dried at a temperature of 25° C. and a pressure of 1 MPa for 2 hours to obtain an initial scaffold. Remove the mold and continue to dry for 36 hours to obtain a three-dimensional scaffold composed of PLGA/calcium carbonate porous composite microspheres.
图3为本实施例制备的由PLGA/碳酸钙多孔复合微球构成的三维支架的表面形貌图。同样支架表面形貌未受破坏。Fig. 3 is the surface topography diagram of the three-dimensional scaffold composed of PLGA/calcium carbonate porous composite microspheres prepared in this example. Similarly, the surface morphology of the stent was not damaged.
实施例3Example 3
称取1g PLGA(LA/GA=75/25,Mw=50kDa)和0.05g碳酸钙粉末加入到5ml二氯甲烷中,在300rpm转速搅拌10min,再在350w超声功率下以250rpm的转速搅拌5min,得到PLGA/碳酸钙的均匀混合油相。称取5g PVA加入到500ml去离子水中,搅拌5min后加热到90℃使PVA溶解,冷却后得到PVA水相。在转速为250rpm搅拌条件下将油相逐滴加入到PVA水溶液中,得到水包油的单乳液,其中油相与水相的体积比为1/100。持续搅拌单乳液20h,得到PLGA/碳酸钙多孔复合微球。收集固化的复合微球,用去离子水洗涤3遍。然后将微球填入到聚四氟乙烯模具中,在温度23℃、压力1MPa下干燥4h,得到初态支架。脱模,继续干燥36h,得到由PLGA/碳酸钙多孔复合微球构成的三维支架。Weigh 1g of PLGA (LA/GA=75/25, Mw=50kDa) and 0.05g of calcium carbonate powder into 5ml of dichloromethane, stir at 300rpm for 10min, then stir at 250rpm for 5min under 350w ultrasonic power, A homogeneous mixed oil phase of PLGA/calcium carbonate was obtained. Weigh 5g of PVA and add it to 500ml of deionized water, stir for 5min, heat to 90°C to dissolve the PVA, and obtain the PVA water phase after cooling. The oil phase was added dropwise into the PVA aqueous solution under the stirring condition of 250 rpm to obtain an oil-in-water single emulsion, wherein the volume ratio of the oil phase to the water phase was 1/100. The single emulsion was continuously stirred for 20 hours to obtain PLGA/calcium carbonate porous composite microspheres. The solidified composite microspheres were collected and washed 3 times with deionized water. Then the microspheres were filled into a polytetrafluoroethylene mold, and dried at a temperature of 23° C. and a pressure of 1 MPa for 4 hours to obtain an initial scaffold. Remove the mold and continue to dry for 36 hours to obtain a three-dimensional scaffold composed of PLGA/calcium carbonate porous composite microspheres.
图4为本实施例制备的由PLGA/碳酸钙多孔复合微球构成的三维支架的表面形貌图。同样支架表面形貌未受破坏。Fig. 4 is a surface topography diagram of a three-dimensional scaffold composed of PLGA/calcium carbonate porous composite microspheres prepared in this example. Similarly, the surface morphology of the stent was not damaged.
实施例4Example 4
本实施例制备水包油的单乳液的过程与实施例1同,继续进行以下步骤:This embodiment prepares the process of the single emulsion of oil-in-water with
持续搅拌(转速为250rpm)单乳液24h,得到PLGA/碳酸钙多孔复合微球。收集固化的复合微球,用去离子水洗涤3遍,在-20℃下冷冻干燥48小时。取干燥的微球,填入到聚四氟乙烯模具中,在70℃加热1h后冷却脱模,得到微球支架。The single emulsion was continuously stirred (rotating at 250 rpm) for 24 hours to obtain PLGA/calcium carbonate porous composite microspheres. The solidified composite microspheres were collected, washed three times with deionized water, and freeze-dried at -20°C for 48 hours. The dried microspheres were taken, filled into a polytetrafluoroethylene mold, heated at 70° C. for 1 hour, and then cooled and demolded to obtain a microsphere scaffold.
图5为本实施例的微球支架的表面形貌图。由图可知,微球表面的孔结构基本消失,只剩下零星的一些孔。Fig. 5 is a surface topography diagram of the microsphere scaffold of this embodiment. It can be seen from the figure that the pore structure on the surface of the microsphere basically disappears, leaving only sporadic pores.
实施例5Example 5
本实施例制备水包油的单乳液的过程与实施例1同,继续进行以下步骤:This embodiment prepares the process of the single emulsion of oil-in-water with
持续搅拌(转速为250rpm)单乳液24h,得到PLGA/碳酸钙多孔复合微球。收集固化的复合微球,用去离子水洗涤3遍,在-20℃下冷冻干燥48小时。取干燥的微球,填入到聚四氟乙烯模具中,置于含有二氯甲烷的密闭容器中处理2min。取出模具,在低压下放置24h以除去残余溶剂。脱模,得到微球支架。The single emulsion was continuously stirred (rotating at 250 rpm) for 24 hours to obtain PLGA/calcium carbonate porous composite microspheres. The solidified composite microspheres were collected, washed three times with deionized water, and freeze-dried at -20°C for 48 hours. Take the dried microspheres, fill them into polytetrafluoroethylene molds, and place them in an airtight container containing dichloromethane for 2 minutes. Take out the mold and place it under low pressure for 24h to remove residual solvent. Release the mold to obtain the microsphere scaffold.
图6为本实施例的微球支架的表面形貌图。由图可知,微球表面的孔结构受到严重破坏。Fig. 6 is a surface topography diagram of the microsphere scaffold of this embodiment. It can be seen from the figure that the pore structure on the surface of the microspheres was severely damaged.
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受所述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。The above-mentioned embodiment is a preferred embodiment of the present invention, but the embodiment of the present invention is not limited by the embodiment, and any other changes, modifications, substitutions and combinations made without departing from the spirit and principle of the present invention , simplification, all should be equivalent replacement methods, and are all included in the protection scope of the present invention.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101392867A CN103212116A (en) | 2013-04-19 | 2013-04-19 | Method for constructing three-dimensional scaffold by polymorphous low-grade adenocarcinoma (PLGA)/calcium carbonate porous composite microsphere |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101392867A CN103212116A (en) | 2013-04-19 | 2013-04-19 | Method for constructing three-dimensional scaffold by polymorphous low-grade adenocarcinoma (PLGA)/calcium carbonate porous composite microsphere |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103212116A true CN103212116A (en) | 2013-07-24 |
Family
ID=48810488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013101392867A Pending CN103212116A (en) | 2013-04-19 | 2013-04-19 | Method for constructing three-dimensional scaffold by polymorphous low-grade adenocarcinoma (PLGA)/calcium carbonate porous composite microsphere |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103212116A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105327405A (en) * | 2015-10-23 | 2016-02-17 | 华南理工大学 | Medicine carrying support used for treating cervicitis and preparation method thereof |
CN109749119A (en) * | 2019-01-31 | 2019-05-14 | 济南大学 | Polylactic acid-hydroxyapatite micro-nano hierarchical structure composite microsphere material and its application |
CN111298196A (en) * | 2020-03-27 | 2020-06-19 | 常州药物研究所有限公司 | Polylactic acid porous microsphere, preparation method and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102772825A (en) * | 2012-07-06 | 2012-11-14 | 华南理工大学 | Polylactic-co-glycolic acid (PLGA)/calcium carbonate compound microsphere with porous shell and preparation method for compound microsphere |
-
2013
- 2013-04-19 CN CN2013101392867A patent/CN103212116A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102772825A (en) * | 2012-07-06 | 2012-11-14 | 华南理工大学 | Polylactic-co-glycolic acid (PLGA)/calcium carbonate compound microsphere with porous shell and preparation method for compound microsphere |
Non-Patent Citations (1)
Title |
---|
葛建华等: "微球法制备聚乳酸/β-磷酸三钙组织工程支架的研究", 《材料科学与工程学报》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105327405A (en) * | 2015-10-23 | 2016-02-17 | 华南理工大学 | Medicine carrying support used for treating cervicitis and preparation method thereof |
CN109749119A (en) * | 2019-01-31 | 2019-05-14 | 济南大学 | Polylactic acid-hydroxyapatite micro-nano hierarchical structure composite microsphere material and its application |
CN109749119B (en) * | 2019-01-31 | 2021-11-02 | 济南大学 | Polylactic acid-hydroxyapatite micro-nano hierarchical structure composite microsphere material and its application |
CN111298196A (en) * | 2020-03-27 | 2020-06-19 | 常州药物研究所有限公司 | Polylactic acid porous microsphere, preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101874751B (en) | Multi-layer porous scaffold and preparation method thereof | |
Valente et al. | Alginate based scaffolds for bone tissue engineering | |
Xu et al. | Polymer blend nanofibers containing polycaprolactone as biocompatible and biodegradable binding agent to fabricate electrospun three-dimensional scaffolds/structures | |
CN102772825B (en) | Polylactic-co-glycolic acid (PLGA)/calcium carbonate compound microsphere with porous shell and preparation method for compound microsphere | |
CN101628131A (en) | Method for preparing ultra-thin porous lamination gradient composite support of tissue engineering | |
CN102357264B (en) | Silk fibroin porous material and preparation method thereof and tissue engineering stent | |
CN102188749A (en) | 3D porous bracket with mesoporous biological glass coating and preparation method thereof | |
CN103948967A (en) | Signal molecule loaded three-dimensional tissue engineering nano-fiber scaffold and preparation method thereof | |
CN101176799A (en) | A method for preparing porous polymer scaffolds for tissue engineering by porogen bonding and leaching out | |
CN104258466B (en) | The preparation method of nano-cellulose/polylactic acid porous scaffold | |
CN103656745B (en) | Gel-poly(lactide-co-glycolide) (PLGA) two-phase gradient transition cartilage-bone repair material and preparation thereof | |
CN114632189A (en) | Elastic porous scaffold and preparation method and application thereof | |
CN107149702A (en) | A kind of preparation of poly-dopamine modified lithium porous support | |
CN103212116A (en) | Method for constructing three-dimensional scaffold by polymorphous low-grade adenocarcinoma (PLGA)/calcium carbonate porous composite microsphere | |
CN102028972A (en) | Honeycomb polymer-based bionic porous scaffold material and preparation method thereof | |
CN108404219B (en) | Small-caliber artificial blood vessel based on freeze casting technology and preparation method thereof | |
CN101703807B (en) | Polylactic acid/chitosan composite nano fiber scaffold, preparation method and application thereof | |
CN101401960B (en) | Glutin-hydroxyapatite composite spheroidal particle, producing method and apparatus thereof | |
CN103394120B (en) | Calcium phosphate-based composite microsphere support and preparation method thereof | |
CN104548210A (en) | Controllable slow-release PLGA microspheres containing dexamethasone transforming growth factor and its preparation | |
CN102492164A (en) | Preparation method of porous fibroin bracket | |
CN102432911B (en) | Particle with surface topological topography, porous bracket and preparation method thereof | |
CN103948963A (en) | Tissue engineering bracket applicable to human body organ construction and preparation method thereof | |
CN103462902A (en) | Method for preparing PLGA/PCL composite microspheres with layered structures and sea-island shapes | |
CN104189954B (en) | A kind of in-situ solidifying tissue engineering bracket and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130724 |